|
KR20040053513A
|
|
Compositions Comprising Extracts of Hericium Erinaceum And Its Use To Lower High Blood Pressure Level
|
|
KR20040053515A
|
|
Compositions Comprising Extracts of Hericium Erinaceum And Its Use For Prevention Against Cancer
|
|
KR20040053514A
|
|
Compositions Comprising Extracts of Hericium Erinaceum And Its Use To Lower Blood Sugar Level
|
|
KR20030083252A
|
|
Compositions Comprising Extracts of Chaga Fungus And The Use Thereof
|
|
KR20030083251A
|
|
Extracts of Chaga Fungus And Stomach Inflammatory Agent Containing The Same
|
|
KR20030033281A
|
|
Utility of Kalopanaxsaponin A Isolated from Kalopananx pictus for Anti-carcinogenic Agent
|
|
KR20030033283A
|
|
Preparation of tectorigenin and kaikasaponin Ⅲ and use thereof as antimutagenic agent
|
|
KR20030033282A
|
|
Extract of Cinnamomi cortex containing Cinnamaldehyde
|
|
KR20030016774A
|
|
Compositions Comprising Antofine And The Use Thereof
|
|
KR20020085507A
|
|
Preparation of 3,4-dicaffeoylquinic acid and use thereof as anti-cholesterol agent
|
|
KR20020081001A
|
|
Compositions Comprising β-Turmerone And The Use Thereof
|
|
KR20020081003A
|
|
Compositions Comprising ar-Turmerone And The Use Thereof
|
|
KR20020081002A
|
|
A Novel Compound, 5-O-Butyl-3,4-Di-O-Caffeoylquinic Acid, The Preparation Methods And The Use Thereof
|
